Envoy Medical (NASDAQ:COCH – Get Free Report) and Vaso (OTCMKTS:VASO – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, analyst recommendations, institutional ownership, earnings, dividends and risk.
Profitability
This table compares Envoy Medical and Vaso’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Envoy Medical | -9,857.26% | N/A | -256.65% |
| Vaso | 2.91% | 9.49% | 3.16% |
Analyst Recommendations
This is a breakdown of current recommendations for Envoy Medical and Vaso, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Envoy Medical | 1 | 0 | 1 | 0 | 2.00 |
| Vaso | 0 | 0 | 0 | 0 | 0.00 |
Earnings & Valuation
This table compares Envoy Medical and Vaso”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Envoy Medical | $241,000.00 | 82.78 | -$20.80 million | ($1.22) | -0.57 |
| Vaso | $86.77 million | 0.36 | $950,000.00 | $0.01 | 17.70 |
Vaso has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Vaso, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
8.6% of Envoy Medical shares are owned by institutional investors. 5.7% of Envoy Medical shares are owned by company insiders. Comparatively, 43.9% of Vaso shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Risk and Volatility
Envoy Medical has a beta of 2.08, indicating that its share price is 108% more volatile than the S&P 500. Comparatively, Vaso has a beta of 0.45, indicating that its share price is 55% less volatile than the S&P 500.
Summary
Vaso beats Envoy Medical on 8 of the 14 factors compared between the two stocks.
About Envoy Medical
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
About Vaso
Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.
Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.
